Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pain control without opioids
pills
NSAIDs are an important part of managing peri-operative pain and should be given preoperatively to manage inflammatory pain.
Delegates invited to be innovative in their approach to small animal analgesia
 
In an interesting lecture at the BSAVA Congress in Birmingham, Karen Walsh from the Willows Veterinary Centre, looked at alternative methods of analgesia to opioids. She said that post surgical pain occurs in up to 50 per cent of human patients. It is not unreasonable to assume that the picture is similar in dogs and cats and surgical pain will certainly affect their quality of life.

NSAIDs are an important part of managing peri-operative pain and should be given preoperatively to manage inflammatory pain. There are concerns about side effects with NSAIDs, 64 per cent of which are gastric in nature. It is important to use licensed veterinary products appropriate for the species being treated.

Karen emphasised that it is possible to minimise the side effects of NSAIDs by taking a good history, not using them concurrently with corticosteroids, and monitoring patients closely for side effects – something that is especially important to emphasise with clients. It is also critical to optimise dosing, use gastro-protective agents and monitor blood biochemistry.

Paracetamol should be used at 10mg/kg every 12 hours in dogs. The licensed product name is Pardale V. Use it in patients that don't tolerate NSAIDs or in addition to manage chronic pain. Paracetamol should not be given to dogs with hepatic disease and must not be given to cats.

Local anaesthetic techniques should not be overlooked for pain control. Although unlicensed specifically for veterinary use, mepivacaine, lidocaine, bupivacaine and ropivacaine can be used, especially for incisional infiltration. There are also 'soaker catheter' techniques using catheters placed deep in the wound, and intraperitoneal infusion and regional nerve blocks can be successfully employed in a range of situations.

The use of constant rate infusions is gaining in popularity. In this instance, it is vital to use the appropriate agent and monitor cases closely, including the total fluid intake. Catheter care is essential because they are technically challenging owing to the need for drivers and pumps. It is important to take into account their contribution to anaesthesia.

Alpha2 agonists produce analgesia by modulating pain at the spinal level. Their major side effects are sedation, depression and hypotension and bradycardia.

Ketamine is very useful substitute for opioids and NSAIDs, especially in the control of somatic and neuropathic pain, rather than visceral pain. It is a Schedule 2 controlled drug and has analgesic effects at sub-anaesthetic doses. Give 0.5 - 1mg/kg intramuscularly or intravenously to provide analgesia for about 20 minutes. This can be followed up constant rate infusion at much lower doses, watching for excitatory side effects.

Lidocaine is useful for managing ocular, visceral and pancreatic pain. Side effects include vasodilation, sedation and neurotoxicity. It is possible to use a combination of morphine, lidocaine and ketamine to control extreme pain, especially associated with cancers.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.